Encycle Therapeutics competitors

Encycle Therapeutics Competitors include Spring Bank Pharmaceuticals, Immupharma, Rezolute and Sangamo BioSciences.
Add company...
Encycle Therapeutics
Encycle Therapeutics
Encycle Therapeutics is a biopharmaceutical company exploiting a proprietary platform technology that enables the rapid synthesis of small-to-medium macrocycles.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Immupharma
Immupharma
ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.
Rezolute
Rezolute
Rezolute develops novel therapeutic products for the diabetes market.
Sangamo BioSciences
Sangamo BioSciences
Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
Founding Date
Founding Date
2012
Founding Date
2002
Founding Date
N/A
Founding Date
2010
Founding Date
1995
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Toronto, CA HQ
Locations
Hopkinton, US HQ
Milford, US
Locations
London, GB HQ
Mulhouse, FR
Sarnen, CH
Locations
Louisville, US HQ
Locations
Richmond, US HQ
Employees
Employees
7
Employees
15
Employees
10
Employees
205% increase
Employees
131
Valuation ($)
Valuation ($)
N/A
Valuation ($)
138.6 m
Valuation ($)
163.4 m
Valuation ($)
53.7 m
Valuation ($)
1.2 b
Twitter followers
Twitter followers
N/A
Twitter followers
1.2 k
Twitter followers
350
Twitter followers
147
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£150.5k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$36.6m (FY, 2017)
Net income
Net income
N/A
Net income
($27.7m) (FY, 2017)
Net income
(£6.2m) (FY, 2017)
Net income
($29.9m) (FY, 2018)
Net income
($54.6m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 4.6m
Total funding raised
$ 14.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 74.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
15

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company
Immupharma
HQ
London, GB
Employees
10

ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.

View company
Rezolute
HQ
Louisville, US
Employees
20↑ 5% increase

Rezolute develops novel therapeutic products for the diabetes market.

View company
Sangamo BioSciences
HQ
Richmond, US
Employees
131

Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

View company